Cargando…
The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years()
PURPOSE: To report the 12 month real life outcomes of ranibizumab treated diabetic macular edema (DME) patients. METHODS: Treatment naïve DME patients treated with ranibizumab were included. Patients were divided into three groups according to their hospital admittance years (2013, 2014, and 2015) a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137827/ https://www.ncbi.nlm.nih.gov/pubmed/30224879 http://dx.doi.org/10.1016/j.sjopt.2018.04.005 |